These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8923114)

  • 1. Moclobemide in the treatment of social phobia.
    Nutt D; Montgomery SA
    Int Clin Psychopharmacol; 1996 Jun; 11 Suppl 3():77-82. PubMed ID: 8923114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moclobemide in social phobia: a controlled dose-response trial.
    Noyes R; Moroz G; Davidson JR; Liebowitz MR; Davidson A; Siegel J; Bell J; Cain JW; Curlik SM; Kent TA; Lydiard RB; Mallinger AG; Pollack MH; Rapaport M; Rasmussen SA; Hedges D; Schweizer E; Uhlenhuth EH
    J Clin Psychopharmacol; 1997 Aug; 17(4):247-54. PubMed ID: 9241002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The International Multicenter Clinical Trial Group on Moclobemide in Social Phobia. Moclobemide in social phobia. A double-blind, placebo-controlled clinical study.
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(2):71-80. PubMed ID: 9177952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-controlled trial of moclobemide in social phobia.
    Schneier FR; Goetz D; Campeas R; Fallon B; Marshall R; Liebowitz MR
    Br J Psychiatry; 1998 Jan; 172():70-7. PubMed ID: 9534836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social phobia: long-term treatment outcome and prediction of response--a moclobemide study.
    Versiani M; Amrein R; Montgomery SA
    Int Clin Psychopharmacol; 1997 Sep; 12(5):239-54. PubMed ID: 9466158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine.
    Versiani M; Nardi AE; Mundim FD; Alves AB; Liebowitz MR; Amrein R
    Br J Psychiatry; 1992 Sep; 161():353-60. PubMed ID: 1393304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders.
    Priest RG; Gimbrett R; Roberts M; Steinert J
    Acta Psychiatr Scand Suppl; 1995; 386():40-3. PubMed ID: 7717094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moclobemide. An update of its pharmacological properties and therapeutic use.
    Fulton B; Benfield P
    Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimensional versus categorical response to moclobemide in social phobia.
    Blanco C; Liebowitz MR
    J Clin Psychopharmacol; 1998 Aug; 18(4):344-6. PubMed ID: 9690704
    [No Abstract]   [Full Text] [Related]  

  • 10. Understanding social phobia. Proceedings of the IVth International Symposium on Moclobemide. Oslo, Norway, 15-16 September 1995.
    Int Clin Psychopharmacol; 1996 Jun; 11 Suppl 3():1-112. PubMed ID: 8923102
    [No Abstract]   [Full Text] [Related]  

  • 11. Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study.
    Lott M; Greist JH; Jefferson JW; Kobak KA; Katzelnick DJ; Katz RJ; Schaettle SC
    J Clin Psychopharmacol; 1997 Aug; 17(4):255-60. PubMed ID: 9241003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIMA--a new concept in the treatment of depression with moclobemide.
    Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication therapy for social phobia.
    Marshall RD; Schneier FR; Fallon BA; Feerick J; Liebowitz MR
    J Clin Psychiatry; 1994 Jun; 55 Suppl():33-7. PubMed ID: 8077172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacotherapy of social phobia.
    Pollack MH; Gould RA
    Int Clin Psychopharmacol; 1996 Jun; 11 Suppl 3():71-5. PubMed ID: 8923113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term treatment of social phobia with moclobemide.
    Versiani M; Nardi AE; Mundim FD; Pinto S; Saboya E; Kovacs R
    Int Clin Psychopharmacol; 1996 Jun; 11 Suppl 3():83-8. PubMed ID: 8923115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIMA: a safe concept in the treatment of depression with moclobemide.
    Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders.
    Liebowitz MR; Hollander E; Schneier F; Campeas R; Welkowitz L; Hatterer J; Fallon B
    Acta Psychiatr Scand Suppl; 1990; 360():29-34. PubMed ID: 2248064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social phobia: diagnosis, severity and implications for treatment.
    Montgomery SA
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S1-6. PubMed ID: 10361959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
    Roth M; Guelfi JD
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical approaches to the treatment of social phobia.
    J Clin Psychiatry; 1994 Aug; 55(8):367-74. PubMed ID: 7915277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.